Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Diamyd Medical starts pilot trial of type 1 diabetes vaccine injected into lymph nodes

Feb. 5, 2015

Isis Pharmaceuticals reports data from phase II study of ISIS-PTP1B Rx in type 2 diabetes

Feb. 5, 2015

Evoke Pharma updates on phase III program for EVK-001 in diabetic gastroparesis

Feb. 4, 2015

Kamada reports interim data from phase I/II extension study of AAT in pediatric type 1 diabetes

Feb. 4, 2015

First preclinical study underway for PharmaCyte's encapsulated Melligen cells for diabetes

Feb. 4, 2015

FDA lifts PPAR partial clinical hold for ETC-1002

Feb. 4, 2015

Viking Therapeutics enters into collaboration for novel THRB agonists for X-ALD

Feb. 4, 2015

Afrezza launched in U.S.

Feb. 3, 2015

FDA approves Glyxambi for type 2 diabetes

Feb. 3, 2015

Repros submits Androxal NDA

Feb. 3, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...